Quantbot Technologies
VTAE

Quantbot Technologies’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Quantbot Technologies’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-113
Closed – – 1559
2016
Q1 		$0 Buy
+113
New +$1.03K ﹤0.01% 1570

Other funds holding VTAE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Cormorant Asset Management
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
DAFNA Capital Management
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Quantbot Technologies's VTAE Position: Q2 2016 in Review

Quantbot Technologies sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q2 2016, closing a stake of 113 shares.

Quantbot Technologies first reported a position in VTAE in Q1 2016 and held it in 1 quarter. The position peaked at $0 in Q1 2016. 71 funds tracked by Wall St. Rank hold VTAE as of Q2 2016.

  • Quantbot Technologies reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q2 2016 after selling out during the quarter.
  • Quantbot Technologies sold 113 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q2 2016.
  • Quantbot Technologies first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2016 and held it in 1 quarter.
  • Quantbot Technologies's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $0 in Q1 2016.
  • 71 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q2 2016.

Based on Quantbot Technologies's 13F filing for Q2 2016, filed 2 Aug 2016.